As of 2026-05-23, the Relative Valuation of Medlab Clinical Ltd (MDC.AX) is (2.62) AUD. This relative valuation is based on P/E multiples. With the latest stock price at 6.60 AUD, the upside of Medlab Clinical Ltd based on Relative Valuation is -139.6%.
The range of the Relative Valuation is (2.09) - (4.37) AUD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.2x - 5.1x | 2.8x |
| Forward P/E multiples | 0.8x - 4.7x | 2.8x |
| Fair Price | (2.09) - (4.37) | (2.62) |
| Upside | -131.7% - -166.3% | -139.6% |
| Date | P/E |